Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

NCT00765661 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure
Renal Failure

Interventions

DRUG: Tacrolimus (Tacro™)
DRUG: Prograf

Sponsor

Veloxis Pharmaceuticals

Collaborators

[object Object]
[object Object]